Optimization of CRISPR/Cas Editing Efficiency in Non-Model Organisms

Advances in CRISPR/Cas technology have revolutionized genome editing, offering unprecedented precision and efficiency in modifying genetic material. In our book, "Optimization of CRISPR/Cas Editing Efficiency in Non-Model Organisms," I explored the complexities of utilizing this powerful tool in research involving non-model organisms. From understanding the molecular machinery of the CRISPR/Cas system to overcoming barriers in delivery and enhancing homology-directed repair efficiency, each chapter offers a comprehensive exploration of key concepts and strategies. Additionally, I addressed the ethical and regulatory considerations inherent in genome editing, providing insights into the evolving regulatory landscape governing the use of CRISPR/Cas technology. Through evidence-based discussions and case studies, this book aims to guide researchers and policymakers in navigating the intricacies of CRISPR/Cas editing in non-model organisms, ultimately fostering responsible and impactful research practices.